Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Biocon Ltd. (BION)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
305.50 -0.90    -0.29%
05:59:59 - Closed. Currency in INR ( Disclaimer )
Type:  Equity
Market:  India
ISIN:  INE376G01013 
S/N:  BIOCON
  • Volume: 17,302,766
  • Bid/Ask: 305.85 / 306.00
  • Day's Range: 300.85 - 314.70
Biocon 305.50 -0.90 -0.29%

NS:BION Financials

 
A brief overview of the NS:BION financials. This summary provides an overview of the most significant critical numbers from each of its financial reports, including the income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health. Users can select to view data from four periods of either annual or quarterly information, allowing them to track financial performance of Biocon Ltd. over time.

Biocon Limited reported earnings results for the second quarter and six months ended September 30, 2023. For the second quarter, the company reported sales was INR 34,623 million compared to INR 23,197 million a year ago. Revenue was INR 36,202 million compared to INR 23,842 million a year ago. Net income was INR 1,256 million compared to INR 469 million a year ago. Basic earnings per share from continuing operations was INR 1.05 compared to INR 0.39 a year ago. Diluted earnings per share from continuing operations was INR 1.05 compared to INR 0.39 a year ago.For the six months, sales was INR 68,849 million compared to INR 44,592 million a year ago. Revenue was INR 71,363 million compared to INR 46,016 million a year ago. Net income was INR 2,270 million compared to INR 1,913 million a year ago. Basic earnings per share from continuing operations was INR 1.9 compared to INR 1.6 a year ago. Diluted earnings per share from continuing operations was INR 1.9 compared to INR 1.6 a year ago.

AnnualQuarterly  
InvestingPro Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

BION Income Statement

Gross margin TTM 63.41%
Operating margin TTM 13.83%
Net Profit margin TTM 8.21%
Return on Investment TTM 5.25%
 Total Revenue  Net Income
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Total Revenue 39537 34623 34226 37739
Gross Profit 27219 23353 22130 19957
Operating Income 5123 3523 3564 7993
Net Income 6600 1256 1014 3132

BION Balance Sheet

Quick Ratio MRQ 0.75
Current Ratio MRQ -
LT Debt to Equity MRQ 79.06%
Total Debt to Equity MRQ 96.15%
 Total Assets  Total Liabilities
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Total Assets 545769 520428
Total Liabilities 302995 295540
Total Equity 242774 242774 224888 224888

BION Cash Flow Statement

Cash Flow/Share TTM 9.81
Revenue/Share TTM 122.38
Operating Cash Flow  -
 Cash  Net Change in Cash
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change in Cash
* In Millions of INR (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

BION Comments

Write your thoughts about Biocon Ltd.
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Advisor Ram
Advisor Ram Oct 18, 2023 8:30AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
May fall 20% tomorow
invest market
INVEST2MARKETS Sep 07, 2023 3:26AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Update BIOCON Revised Stop Loss 264 from 254 (Profit +2, Even If Rev SL Hit)
Sanjeev batra
Sanjeev batra Jun 30, 2023 6:12AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
will it come down on Monday
Positional Profits
Positional Profits Jan 17, 2023 3:15AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Buy & Hold Biocon CMP 247.90 Tar 320+++++ Maintain SL below 233 Positional_Profits
invest market
INVEST2MARKETS Jan 16, 2023 12:45AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Delivery Buy Biocon Above 253 Stop Loss 246 Targets 264-270
Lokesh Anand
Lokesh Anand Jan 12, 2023 12:59AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
break 247 then next target 211 useless stock to trade/ invest
Lokesh Anand
Lokesh Anand Jan 12, 2023 12:59AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
see my analysis by mid Feb breaking 211 very possible
Lokesh Anand
Lokesh Anand Dec 29, 2022 1:48AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
End of Biocon era.. soon will break 211 no research on bio, improper profits
Manish Kateshiya
Manish Kateshiya Dec 19, 2022 8:43AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
buy biocon for the tgt of 285,295 December expiry
Rohan Kumar
Rohan Kumar Dec 13, 2022 8:41AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
now it's time to buy
Mohamed Mahathir
Mohamed Mahathir Jul 01, 2022 1:55AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What is the status of biocon now…??
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email